DermTech

www.dermtech.com

Welcome to the new era of skin cancer detection. At DermTech we bring precision to the practice of dermatology through non-invasive genomic testing. And we developed the Smart Sticker™ that's making it possible. The DermTech Smart Sticker collects an RNA sample by painlessly lifting skin cells off the entire surface of a mole. This gives doctors the power to diagnose skin cancer in its earliest stages—without a scalpel, without cutting, without scarring. After collection, stickers are sent to our team of scientists in the Gene Lab, the only commercial lab to extract nucleic acids and other proteins from non-invasive skin samples. We amplify RNA molecules to detect two specific genes that are highly predictive of melanoma—PRAME and LINC00518. This process provides 10,000x greater precision in the ability to detect melanoma. We have created the step before the scalpel—a tool doctors have never had before. Now the doctor has the choice of using a non-invasive, highly accurate test to check for melanoma without cutting. And this is just the beginning. We are developing other tests using the Smart Sticker that will further advance early disease detection. Help us change the world of dermatology. Together let’s diagnose skin cancer early and make melanoma a disease of the past.

Read more

Reach decision makers at DermTech

Lusha Magic

Free credit every month!

Welcome to the new era of skin cancer detection. At DermTech we bring precision to the practice of dermatology through non-invasive genomic testing. And we developed the Smart Sticker™ that's making it possible. The DermTech Smart Sticker collects an RNA sample by painlessly lifting skin cells off the entire surface of a mole. This gives doctors the power to diagnose skin cancer in its earliest stages—without a scalpel, without cutting, without scarring. After collection, stickers are sent to our team of scientists in the Gene Lab, the only commercial lab to extract nucleic acids and other proteins from non-invasive skin samples. We amplify RNA molecules to detect two specific genes that are highly predictive of melanoma—PRAME and LINC00518. This process provides 10,000x greater precision in the ability to detect melanoma. We have created the step before the scalpel—a tool doctors have never had before. Now the doctor has the choice of using a non-invasive, highly accurate test to check for melanoma without cutting. And this is just the beginning. We are developing other tests using the Smart Sticker that will further advance early disease detection. Help us change the world of dermatology. Together let’s diagnose skin cancer early and make melanoma a disease of the past.

Read more
icon

Country

icon

State

California

icon

City (Headquarters)

San Diego

icon

Estimated Revenue

$1,000,000 to $5,000,000

icon

Social

  • icon
  • icon

Employees statistics

View all employees

Potential Decision Makers

  • Vice President of Clinical Operations and Research Contracts

    Email ****** @****.com
    Phone (***) ****-****
  • Member Board of Directors

    Email ****** @****.com
    Phone (***) ****-****
  • Senior Director , Investor Relations

    Email ****** @****.com
    Phone (***) ****-****
  • Senior Director , Cyber Security

    Email ****** @****.com
    Phone (***) ****-****

Technologies

(86)

Reach decision makers at DermTech

Free credits every month!

My account

DermTech FAQ

Sign up now to uncover all the contact details